Apnimed, Inc. (APMD) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$28.34

From 52W high−10.91%

Volume3.14M

Market cap$1.21B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$28.34

From 52W high

−10.91%

Volume

3.14M

Market cap

$1.21B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

59.9

MomentumView details →

1D Return

+3.17%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+3.17%

YTD Return

—

1Y Return

—

RSI (14)

59.9

vs 50D SMA

—

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$3.92

EPS Surprise

905.47%

Beats (12Q)

1/12

Next Q EPS Est

—

Avg Surprise (4Q)

905.47%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsDec 2, 2026 →

Latest newsMore news →

No recent news for APMD.

Similar companies

Aktis Oncology, Inc.AKTS Alto Neuroscience, Inc.ANRO Replimune Group, Inc.REPL Odyssey Therapeutics, Inc.ODTX Maze Therapeutics, Inc.MAZE ST嘉必优688089.SH Find similar companies →

Latest newsMore news →

No recent news for APMD.